Literature DB >> 26043325

What has serotonin to do with depression?

Philip J Cowen1, Michael Browning1.   

Abstract

Entities:  

Year:  2015        PMID： 26043325      PMCID： PMC4471964          DOI： 10.1002/wps.20229

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  21 in total

Review 1.  Opponent interactions between serotonin and dopamine.

Authors:  Nathaniel D Daw; Sham Kakade; Peter Dayan
Journal:  Neural Netw       Date:  2002 Jun-Jul

2.  Optogenetic activation of dorsal raphe serotonin neurons enhances patience for future rewards.

Authors:  Kayoko W Miyazaki; Katsuhiko Miyazaki; Kenji F Tanaka; Akihiro Yamanaka; Aki Takahashi; Sawako Tabuchi; Kenji Doya
Journal:  Curr Biol       Date:  2014-08-21       Impact factor: 10.834

Review 3.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

Review 4.  Serotonin and dopamine: unifying affective, activational, and decision functions.

Authors:  Roshan Cools; Kae Nakamura; Nathaniel D Daw
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

5.  Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker?

Authors:  R M Berman; M Narasimhan; H L Miller; A Anand; A Cappiello; D A Oren; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1999-05

Review 6.  Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies.

Authors:  H G Ruhé; N S Mason; A H Schene
Journal:  Mol Psychiatry       Date:  2007-01-16       Impact factor: 15.992

Review 7.  Serotonin and depression: pathophysiological mechanism or marketing myth?

Authors:  Philip J Cowen
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

8.  Low-serotonin levels increase delayed reward discounting in humans.

Authors:  Nicolas Schweighofer; Mathieu Bertin; Kazuhiro Shishida; Yasumasa Okamoto; Saori C Tanaka; Shigeto Yamawaki; Kenji Doya
Journal:  J Neurosci       Date:  2008-04-23       Impact factor: 6.167

9.  An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.

Authors:  Rudolf Uher; Katherine E Tansey; Tracy Dew; Wolfgang Maier; Ole Mors; Joanna Hauser; Mojca Zvezdana Dernovsek; Neven Henigsberg; Daniel Souery; Anne Farmer; Peter McGuffin
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

Review 10.  The role of serotonin in the regulation of patience and impulsivity.

Authors:  Katsuhiko Miyazaki; Kayoko W Miyazaki; Kenji Doya
Journal:  Mol Neurobiol       Date:  2012-01-20       Impact factor: 5.590
View more
  53 in total

Review 1.  The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.

Authors:  Robin L Carhart-Harris; Guy M Goodwin
Journal:  Neuropsychopharmacology       Date:  2017-04-26       Impact factor: 7.853

Review 2.  Depression and glioblastoma, complicated concomitant diseases: a systemic review of published literature.

Authors:  Luke Mugge; Tarek R Mansour; Megan Crippen; Yasaman Alam; Jason Schroeder
Journal:  Neurosurg Rev       Date:  2018-08-09       Impact factor: 3.042

3.  Acute tryptophan loading decreases functional connectivity between the default mode network and emotion-related brain regions.

Authors:  Yacila I Deza-Araujo; Philipp T Neukam; Michael Marxen; Dirk K Müller; Thomas Henle; Michael N Smolka
Journal:  Hum Brain Mapp       Date:  2018-12-25       Impact factor: 5.038

4.  Dietary Inflammatory Potential and the Risk of Incident Depression in Adults: A Systematic Review.

Authors:  Sorayya Kheirouri; Mohammad Alizadeh
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

5.  A Load to Find Clinically Useful Biomarkers for Depression.

Authors:  Matea Nikolac Perkovic; Marina Sagud; Lucija Tudor; Marcela Konjevod; Dubravka Svob Strac; Nela Pivac
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Perioperative Considerations for Patients With Major Depressive Disorder Undergoing Surgery.

Authors:  Edwin N Aroke; Alexis N Robinson; Bryan A Wilbanks
Journal:  J Perianesth Nurs       Date:  2020-01-16       Impact factor: 1.084

7.  How do drugs for psychiatric disorders work?

Authors:  C J Harmer; P J Cowen
Journal:  Epidemiol Psychiatr Sci       Date:  2017-11-09       Impact factor: 6.892

8.  The effects of serotonin modulation on medial prefrontal connectivity strength and stability: A pharmacological fMRI study with citalopram.

Authors:  D Arnone; T Wise; C Walker; P J Cowen; O Howes; S Selvaraj
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-02-01       Impact factor: 5.067

9.  Selective serotonin reuptake inhibitor attenuates the hyperresponsiveness of TLR2+ and TLR4+ Th17/Tc17-like cells in multiple sclerosis patients with major depression.

Authors:  Marisa C Sales; Taissa M Kasahara; Priscila M Sacramento; Átila D Rossi; Marcos Octávio S D Cafasso; Hugo A A Oyamada; Joana Hygino; Fabianna Alvim; Regis M Andrade; Cláudia Cristina Vasconcelos; Cleonice A M Bento
Journal:  Immunology       Date:  2020-11-23       Impact factor: 7.397

Review 10.  Widespread Morphometric Abnormalities in Major Depression: Neuroplasticity and Potential for Biomarker Development.

Authors:  Cynthia H Y Fu; Yong Fan; Christos Davatzikos
Journal:  Neuroimaging Clin N Am       Date:  2019-11-08       Impact factor: 2.264
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.